181 related articles for article (PubMed ID: 9221576)
1. [Etiology and epidemiology of hepatocellular carcinoma].
Brodanová M
Vnitr Lek; 1997 Mar; 43(3):157-61. PubMed ID: 9221576
[TBL] [Abstract][Full Text] [Related]
2. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
3. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
Macías Rodríguez MA; Rendón Unceta P; Tejada Cabrera M; Infante Hernández JM; Correro Aguilar F; Díaz García F; Benítez Rodríguez E; Mangas Rojas A; Martín Herrera L
Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763
[TBL] [Abstract][Full Text] [Related]
5. [Epidemiology and diagnosis of hepatocellular carcinomas in cirrhosis].
Duvoux C
Ann Chir; 1998; 52(6):511-7. PubMed ID: 9752500
[TBL] [Abstract][Full Text] [Related]
6. [Alcoholic liver diseases in Japan and modification by hepatitis virus].
Horie Y; Yamagishi Y; Ishii H
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Oct; 38(5):403-14. PubMed ID: 14639919
[TBL] [Abstract][Full Text] [Related]
7. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
Tischoff I; Tannapfel A
Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
[TBL] [Abstract][Full Text] [Related]
8. [Hepatocellular carcinoma: rising incidence of hepatitis C virus-associated cases at a university clinic in Germany].
Erhardt A; Theobald I; Petry W; Röhrborn A; Heintges T; Wettstein M; Häussinger D
Dtsch Med Wochenschr; 2002 Dec; 127(50):2665-8. PubMed ID: 12481236
[TBL] [Abstract][Full Text] [Related]
9. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
Squadrito G; Pollicino T; Cacciola I; Caccamo G; Villari D; La Masa T; Restuccia T; Cucinotta E; Scisca C; Magazzu D; Raimondo G
Cancer; 2006 Mar; 106(6):1326-30. PubMed ID: 16453330
[TBL] [Abstract][Full Text] [Related]
10. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
11. [Hepatocellular carcinoma--epidemiology and treatment].
Małkowski P; Pacholczyk M; Łagiewska B; Adadyński L; Wasiak D; Kwiatkowski A; Chmura A; Czerwiński J
Przegl Epidemiol; 2006; 60(4):731-40. PubMed ID: 17682755
[TBL] [Abstract][Full Text] [Related]
12. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
[TBL] [Abstract][Full Text] [Related]
13. Manganese superoxide dismutase activity and incidence of hepatocellular carcinoma in patients with Child-Pugh class A liver cirrhosis: a 7-year follow-up study.
Clemente C; Elba S; Buongiorno G; Guerra V; D'Attoma B; Orlando A; Russo F
Liver Int; 2007 Aug; 27(6):791-7. PubMed ID: 17617122
[TBL] [Abstract][Full Text] [Related]
14. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
Nair S; Mason A; Eason J; Loss G; Perrillo RP
Hepatology; 2002 Jul; 36(1):150-5. PubMed ID: 12085359
[TBL] [Abstract][Full Text] [Related]
15. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
16. [Hepatocellular carcinoma].
Andersen IB; Sørensen TI; Krogsgaard K
Ugeskr Laeger; 1989 Feb; 151(9):550-3. PubMed ID: 2538017
[TBL] [Abstract][Full Text] [Related]
17. The epidemiology of hepatocellular carcinoma.
Johnson PJ
Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):845-9. PubMed ID: 8889448
[TBL] [Abstract][Full Text] [Related]
18. Etiology of hepatocellular carcinoma in Argentina: results of a multicenter retrospective study.
Fassio E; Míguez C; Soria S; Palazzo F; Gadano A; Adrover R; Landeira G; Fernández N; García D; Barbero R; Perelstein G; Ríos B; Isla R; Civetta E; Pérez Ravier R; Barzola S; Curciarello J; Colombato LA; Jmeniltzky A
Acta Gastroenterol Latinoam; 2009 Mar; 39(1):47-52. PubMed ID: 19408739
[TBL] [Abstract][Full Text] [Related]
19. NASH and HCC.
Page JM; Harrison SA
Clin Liver Dis; 2009 Nov; 13(4):631-47. PubMed ID: 19818310
[TBL] [Abstract][Full Text] [Related]
20. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]